Adam Fridhammar - Dissemin

Language
Login

All papers authored by Adam Fridhammar

This paper was not found in any repository, but could be made available legally by the author.

2022 Ida Skarping

ORCID

, Kristoffer Nilsson

ORCID

ORCID

, Adam Fridhammar

ORCID

, Mattias Ohlsson

ORCID

ORCID

, Pär-Ola Bendahl

ORCID

, Katarina Steen Carlsson

ORCID

ORCID

The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer

Upload

This paper is made freely available by the publisher.

2020 Adam Fridhammar

ORCID

, Ulrika Axelsson, Ulf Persson, Anders Bjartell, Carl A. K. Borrebaeck

The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development

Download from link.springer.com

This paper is made freely available by the publisher.

Michael Willis

ORCID

, Adam Fridhammar

ORCID

, Jens Gundgaard, Andreas Nilsson

ORCID

, Pierre Johansen

ORCID

Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM

Download from link.springer.com

This paper is made freely available by the publisher.

2019 Åsa Ericsson, Adam Fridhammar

ORCID

Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden

Download from tandfonline.com

This paper was not found in any repository, but could be made available legally by the author.

2018 Linus Aronsson, Daniel Ansari, Bodil Andersson, Ulf Persson, Adam Fridhammar

ORCID

, Roland Andersson

Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype

Upload

This paper is made freely available by the publisher.

Åsa Ericsson

ORCID

, Divina Glah, Maria Lorenzi, Jeroen P. Jansen, Adam Fridhammar

ORCID

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2016 Adam Lundqvist

ORCID

, Ida Ahlberg, Frida Hjalte, Mats Ekelund

Direct and indirect costs for anal fistula in Sweden

Upload

Missing publications? Search for publications with a matching author name.